AzTrials
AzTrials

DeliriumNCT02356523

Incidence and Prognostic Value of Delirium in Patients With Acute Coronary Syndromes

An observational study of Delirium, run by Ospedale San Donato at 1 site in Italy.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The Purpose of this study is to evaluate the incidence of delirium in patients with acute coronary syndromes admitted to a Intensive Care Unit Patients. Read more about this study

Who is it for?
Ages 65 years and older
Conditions the study is for
Delirium
What is being tested?
Confusion Assessment Method
How many people
700 participants
Where
1 siteItaly
Study dates
Jan 2014to Oct 2015
How long will I take part?
6 Months
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Study population: Patients admitted in Cardiac Intensive Care Unit for any condition

Who may be able to join

  • Admission in Cardiac Intensive Care Unit
  • Age ≥ 65 years

Who cannot join

  • none

Trial locations and contacts

1 site in 1 country.

Italy1 site
  • Cardiovascular Department, Ospedale S.Donato

    Arezzo, AR, 52100

Other trials in Italy

About this study

Official title: Long-term Prognostic Value of Delirium in Elderly Patients With Acute Coronary Syndrome Admitted to Two Cardiac Intensive Care Units: a Prospective Study

The Purpose of this study is to evaluate the incidence of delirium in patients with acute coronary syndromes admitted to a Intensive Care Unit Patients.

Read the detailed description

The present study is a prospective, two-centre registry aimed at assessing the incidence, prevalence and prognostic significance of delirium in elderly patients with acute coronary syndromes

Conditions
Delirium
Being tested
Confusion Assessment Method
Medical subject headings
Delirium

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Confusion Assessment MethodDiagnostic test

    Administration of Confusion Assessment Method at patent over 65 years at admission and every day until discharge

Study groups in NCT02356523
Study groupRoleWhat they receive
Delirium patientsPatients positive to Confusion Assessment Method (CAM) assessment ad admission and during hospital stay
Receives: Diagnostic Test: Confusion Assessment Method
control groupPatients negative to Confusion Assessment Method (CAM) assessment ad admission and during hospital stay
Receives: Diagnostic Test: Confusion Assessment Method

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. diagnosis of delirium by confusion assessment method

    incidence of delirium in elderly patients with coronary acute syndromes

    Measured: within 24 hours of admission

Secondary outcomes (1)
  1. adverse events incidence

    any adverse event occurred to patients during hospital stay not due to the illness

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Feb 2015 (estimated)
  2. Study startJan 2014
  3. Primary completionMar 2015
  4. Study completionOct 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
700 participants (actual)
Target duration
6 Months
IDs, dates and publications
ClinicalTrials.gov ID
NCT02356523
Sponsor's protocol ID
Arezzo014
Status last verified
Mar 2023
First submitted
2 Feb 2015
Last updated
15 Mar 2023
Results posted
No
Data monitoring committee
No
Individual data sharing
Undecided: recording in excel files

Publications

  • Inouye SK. Delirium in hospitalized older patients: recognition and risk factors. J Geriatr Psychiatry Neurol. 1998 Fall;11(3):118-25; discussion 157-8. doi: 10.1177/089198879801100302.

    PubMed 9894730
  • Hsieh SJ, Ely EW, Gong MN. Can intensive care unit delirium be prevented and reduced? Lessons learned and future directions. Ann Am Thorac Soc. 2013 Dec;10(6):648-56. doi: 10.1513/AnnalsATS.201307-232FR.

    PubMed 24364769
  • McPherson JA, Wagner CE, Boehm LM, Hall JD, Johnson DC, Miller LR, Burns KM, Thompson JL, Shintani AK, Ely EW, Pandharipande PP. Delirium in the cardiovascular ICU: exploring modifiable risk factors. Crit Care Med. 2013 Feb;41(2):405-13. doi: 10.1097/CCM.0b013e31826ab49b.

    PubMed 23263581

Questions about this trial

What is this clinical trial studying?

An observational study of Delirium, run by Ospedale San Donato at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 15 Mar 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

diagnosis of delirium by confusion assessment method (time frame: within 24 hours of admission). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02356523, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Mar 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in